Last quarter (Q4 2023), Forte Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Forte Biosciences's net income was $-5.87M. See Forte Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	-	$ 0.00	$ 0.00
Cost of Revenue	-	-	-	$ -100.00K	-	-
Gross Profit	-	-	-	$ 100.00K	-	-
Operating Expense	$ 32.49M	$ 32.49M	$ 13.90M	$ 21.49M	$ 14.22M	$ 4.06M
Operating Income	$ -32.49M	$ -32.49M	$ -13.90M	$ -21.49M	$ -14.22M	$ -4.06M
Net Non Operating Interest Income Expense	$ 1.12M	$ 1.12M	-	-	-	$ 2.52K
Other Income Expense	$ 114.00K	$ 114.00K	$ -17.00K	$ 222.00K	$ -32.26M	$ -6.85K
Pretax Income	$ -31.48M	$ -31.48M	$ -13.88M	$ -21.71M	$ -46.49M	$ -4.07M
Tax Provision	-	-	$ -79.00K	$ -479.00K	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -31.48M	$ -31.48M	$ -13.88M	$ -21.71M	$ -46.49M	$ -4.07M
Basic EPS	$ -1.13	$ -1.00	$ -0.80	$ -1.55	$ -6.32	$ -0.38
Diluted EPS	$ -1.13	$ -1.00	$ -0.80	$ -1.55	$ -6.32	$ -0.38
Basic Average Shares	$ 125.90M	$ 31.48M	$ 17.38M	$ 13.97M	$ 7.36M	$ 10.80M
Diluted Average Shares	$ 125.90M	$ 31.48M	$ 17.38M	$ 13.97M	$ 7.36M	$ 10.80M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 32.49M	$ 32.49M	$ 13.90M	$ 21.39M	$ 14.22M	$ 4.06M
Net Income From Continuing And Discontinued Operation	$ -31.48M	$ -31.48M	$ -13.88M	$ -21.71M	$ -46.49M	$ -4.07M
Normalized Income	$ -19.53M	$ -24.87M	$ -13.96M	-	$ -14.43M	$ -4.07M
Interest Expense	-	-	-	-	-	-
EBIT	$ -32.60M	$ -32.60M	$ -13.88M	$ -21.71M	$ -14.22M	$ -4.06M
EBITDA	$ -32.59M	$ -32.59M	$ -13.88M	$ -21.67M	$ -14.17M	$ -4.05M

Currency in USD

Forte Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing